Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

Cardiovascular disease is the leading cause of death in women. Decades of grassroots
campaigns have helped to raise awareness about the impact of cardiovascular disease in …

Abstract Aim The “2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS
Guideline for the Management of Lower Extremity Peripheral Artery Disease” provides …

As populations age worldwide, the burden of valvular heart disease has grown
exponentially, and so has the proportion of affected women. Although rheumatic valve …

Remarkable recent advances have revolutionized the field of heart failure. Survival has
improved among individuals with heart failure and a reduced ejection fraction and for the …

Patients with type 2 diabetes mellitus (T2DM) can have multiple comorbidities and
premature mortality due to atherosclerotic cardiovascular disease, hospitalization with heart …

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide.
There is robust evidence of heterogeneity in underlying mechanism, manifestation …

Although some progress has been made in the last 3 decades to increase the number of
women in clinical cardiology trials, review of recent cardiovascular literature demonstrates …

Cardiovascular disease (CVD) remains the leading cause of death for both women and men
worldwide. In the United States (US), there are significant disparities in cardiovascular risk …

Hypertension is the leading risk factor for cardiovascular disease and premature death
among women globally. However, there is a fundamental lack of knowledge regarding the …